Biopharmaceuticals - A Global Market Overview

Published Date: Apr 2010

Report Code: BT001ARCH

Pages:240

Charts:131

Intense research efforts made biopharmaceuticals the most successful products in various therapeutic areas such as Neurology, Infectious Diseases, Cardiovascular, Oncology etc. Undoubtedly, all the major pharmaceuticals are, now, engaged in doing research for new biopharmaceutical active ingredients. Biopharma active ingredients are containing in about 50% of the newly approved drugs. The future of biopharmaceuticals is to be projected bright as the market share is growing gradually. In terms of market revenue, out of total pharma market the biopharmaceutical products were accounted for about 10% in 2006 and are projected to account for about 15% by 2015.

Biopharmaceutical products analyzed in this study comprise Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, Granulocyte-Colony Stimulating Factor, Recombinant Human Insulin, Interferons, Human Growth Hormones and Other. The report also analyzes the market for biopharmaceutical therapeutic areas including Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other.

The global market for biopharmaceuticals is projected to reach US$182.5 billion by 2015, registering a CAGR of 12.4% during the period 2006-2015. The study includes 131 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in USD by geographic regions and the product segments.

The report analyses the biopharmaceuticals market for global and the regional markets including North America, Western Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 10 independent countries across North America - the United States and Canada; Europe - Germany, The United Kingdom, France, Italy and Spain; Asia-Pacific - Japan, China and India.

This study profiles 53 key global players and 87 major players across North America - 37; Western Europe - 18; Asia-Pacific - 30; and Rest of World - 2. The report also provides the listing of the companies engaged in research, technology development, manufacturing and the supply of biopharmaceuticals. The global list of companies covers addresses, contact numbers and the website addresses of 382 companies.

1. GLOBAL MARKET PERSPECTIVE
1.1 Introduction
1.2 Product Segmentation
1.2.1 Monoclonal Antibodies
1.2.2 Biotechnology Vaccines
1.2.3 Erythropoietin
1.2.3.1 Therapeutic Application
1.2.4 Granulocyte-Colony Stimulating Factor
1.2.4.1 Therapeutic Application
1.2.5 Recombinant Human Insulin
1.2.6 Interferons
1.2.7 Human Growth Hormones
1.2.7.1 Therapeutic Application
Anti-Aging Agent
Athletic Advantages
Side Effects

1.3 Application Analysis
1.3.1 End use Markets for Biopharmaceutical Products
1.3.2 Top-25 Biopharmaceutical Blog Buster Drugs

1.4 Market Trends
1.4.1 Big Pharma Companies to Adopt Virtual Pharma Model for Faster Lead Time
1.4.2 Biopharmaceutical Research Network for Producing Monoclonal Antibodies
1.4.3 European Biopharmaceutical Enterprises to Establish European Biopharmaceutical Innovation Fund
1.4.4 Government Policy to Boost Biopharmaceuticals market in China
1.4.5 Future Looks Bright for Indian Biopharmaceuticals Market

1.5 Key Global Players
1.6 Key Business Trends
Pharmaxis Takeover Topigen pharma
Astrazeneca Settles Patent Agreement with Teva Pharmaceuticals
Molecular Insight Pharmaceuticals reduces personnel to synchronize operations
Keryx concludes SPA agreement for Phase III clinical trial for Zerenex
Merz to Bag BioForm Medical
Anika acquires Fidia Advanced Biopolymers
Teva-KOWA to acquire stake in Taisho Pharmaceutical
Novartis Acquires Corthera Inc
AstraZeneca acquires Novexel
Array BioPharma Partners with Amgen for Type 2 Diabetes
BD acquires HandyLab
D-Pharm collaborates with Wanbang Biopharmaceuticals
GPC Biotech AG merges with Agennix AG
China Biopharmaceuticals merges with NeoStem
Bio-Rad signs partnership with Biotest AG for diagnostics
Sanofi-Aventis Acquires France based FOVEA
Sandoz Closes acquisition of EBEWE Pharma
Sanofi-Aventis Acquires Merck’s Interest in Merial
Johnson & Johnson acquires Cougar Biotechnology
Baxter signs agreement with Edwards Life sciences for CRRT
MannKind acquires insulin assets from Pfizer
Alder expands collaboration with Schering-Plough
Akela Pharma Merges with Nventa Biopharmaceuticals
Takeda acquires IDM Pharma
GVK Biosciences Signs Clinical Research Partnership with Excel Pharma
Acquisition of Medley strengthens Sanofi-Aventis position in Brazil
Kendrick acquisition reinforces Sanofi’s emerging market maneuver
Roche acquires Genentech
Johnson & Johnson takes over Mentor Corporation
Johnson & Johnson acquires Omrix Biopharmaceuticals Inc.
Teva acquires Barr
GlaxoSmithKline acquires BMS Pakistan
Roche signs agreement to takeover Memory Pharmaceuticals
Lilly acquires ImClone Systems
Acquisition of Alvedon boosts GSK’s analgesic portfolio
GSK acquires Genelabs Technologies
Novartis Takeover Nektar
GSK purchase of Laclede’s Biotene
Sanofi Pasteur Acquires Acambis
Lilly takes over SGX
Bayer acquires preclinical anti-cancer program from Nycomed
Thermo Fisher takes over FIBERLite Centrifuge
Teva Bags Bentley Pharmaceuticals
Thermo Fisher Acquires Affinity BioReagents
Intas Biopharma Bags Biologisc Process Development
Boehringer Ingelheim acquires Actimis Pharmaceuticals
Itero Biopharma collaborates with Biological E. Ltd.
GVK Bio signs Pact with Wyeth Pharmaceuticals for drug discovery
Takeda acquires Millennium
BD Acquires Cytopeia
DOR BioPharma Signs Development license agreement with Harvard
Abbott Forms Joint Venture with Takeda
Takeda acquires Paradigm Therapeutics
Thermo Fisher acquires Finnzymes
Dr. Reddy’s completes two acquisitions
EUSA Pharma Acquires Cytogen
Roche acquires Piramed
Dr. Reddy’s Bags Italian Jet Generici Srl.
AVI BioPharma acquires Ercole Biotech
Teva acquires CoGenesys
Roche bullish on biopharmaceuticals
GlaxoSmithKline acquires Reliant Pharmaceuticals
Amgen acquires Ilypsa
Amgen takes over Alantos

1.7 Key Product Trends
FDA Approves Quick Review for Keryx treatment
Cipla Introduces generic drug to treat H1N1
Glenmark Generics (Europe) launches its first four products for the UK market
Keryx Gains orphan drug status for KRX-040
Promius Pharma releases Promiseb™
Amgen to partner GlaxoSmithKline to commercialize denosumab in Europe
Bayer gains entitlement to Bioton’s insulin SciLin®
Bio-Rad announces Bio-Plex Pro
Glenmark Unveils Azathioprine in the US.
Promius Introduces EPICERAM®
Biocon and Abraxis Bioscience Itroduces Abraxane in India
Glenmark Generics launches Tablet for Hypertension
BD Biosciences launches high-performance calcium dye assay kit

1.8 Global Market Overview
1.8.1 Market Overview by Biopharmaceutical Product Segment
1.8.2 Biopharmaceutical Product Market Overview by Global Region
1.8.2.1 Monoclonal Antibodies
1.8.2.2 Biotech Vaccines
1.8.2.3 Erythropoietin
1.8.2.4 Granulocyte-Colony Stimulating Factor
1.8.2.5 Recombinant Human Insulin
1.8.2.6 Interferons
1.8.2.7 Human Growth Hormones
1.8.2.8 Other Biopharmaceuticals
1.8.3 Biopharmaceutical Therapeutic Market Overview by Global Region
1.8.3.1 Oncology
1.8.3.2 Neurology
1.8.3.3 Diabetes
1.8.3.4 Infectious Diseases
1.8.3.5 Cardiovascular
1.8.3.6 Other Disease Areas

2. REGIONAL MARKET PERSPECTIVE
2.1 Regional Market Overview
2.1.1 North America
2.1.1.2 Market Overview by North American Region
2.1.1.3 Market Overview by Biopharmaceutical Product
2.1.1.4 Market Overview by Biopharmaceutical Therapeutic Area
2.1.1.5 Biopharmaceutical Product Market Overview by North American Region
Monoclonal Antibodies
Biotech Vaccines
Erythropoietin
Granulocyte-Colony Stimulating Factor
Recombinant Human Insulin
Interferons
Human Growth Hormones
Other Biopharmaceuticals
2.1.1.6 Major Market Players
Abbott Laboratories (USA)
Accentia Biopharmaceuticals, Inc. (USA)
Advanced Life Sciences, Inc. (USA)
Alder Biopharmaceuticals, Inc. (USA)
Alexion Pharma (USA)
Ambrilia Biopharma Inc. (USA)
Amgen (USA)
Analytical Biological Services Inc. (USA)
Array BioPharma (USA)
Astellas Pharma (USA)
Atlanta Biologicals, Inc. (USA)
AVI BioPharma (USA)
Baxter Bioscience Corporation (USA)
BD Biosciences (USA)
Biodel Inc. (USA)
Biogen Idec (USA)
Bio-Rad Laboratories, Inc. (USA)
DNA Gateway International, Inc. (USA)
Eli Lilly (USA)
EUSA Pharma (USA)
Genentech (USA)
Genzyme (USA)
Helix BioPharma Corp. (USA)
Hemispherx Biopharma, Inc. (USA)
IBI International LLC (USA)
Johnson & Johnson's (USA)
Millipore Corporation (USA)
Neurobiological Technologies, Inc. (USA)
Novozymes Biopharma (USA)
OSI Pharmaceuticals, Inc. (USA)
Pfizer Inc. (USA)
Procter & Gamble Pharmaceuticals (USA)
Provenance BioPharmaceuticals (USA)
Sigma-Aldrich Corporation (USA)
Soligenix, Inc. (USA)
ZymoGenetics (USA)
Pacgen Biopharmaceuticals Corporation (Canada)

2.1.1.7 North American Market Overview by Country
The United States
Canada

2.1.2 Western Europe
2.1.2.1 Market Overview by Western Europe Region
2.1.2.3 Market Overview by Biopharmaceutical Product
2.1.2.3 Market Overview by Biopharmaceutical Therapeutic Area
2.1.2.4 Biopharmaceutical Product Market Overview by Western Europe Region
Monoclonal Antibodies
Biotech Vaccines
Erythropoietin
Granulocyte-Colony Stimulating Factor
Recombinant Human Insulin
Interferons
Human Growth Hormones
Other Biopharmaceuticals
2.1.2.5 Major Market Players
Agennix AG (Germany)
AstraZeneca (United Kingdom)
Bayer AG (Germany)
Boehringer Ingelheim (Germany)
Bristol-Myers Squibb Belgium NV (Belgium)
CellGenix Technologie Transfer GmbH (Germany)
GlaxoSmithKline Pharmaceuticals Limited (United Kingdom)
Merck Serono S.A (Switzerland)
Novartis (Switzerland)
Novo Nordisk (Denmark)
PromoCell GmbH (Germany)
Pronova BioPharma (Norway)
Roche (Switzerland)
Sandoz Biogenerics (Germany)
Sanofi-Aventis (France)
Schering Ag (Germany)
Solvay Pharma & Cie (Belgium)
UCB S.A. (Belgium)
2.1.2.6 Western Europe Market Overview by Country
Germany
The United Kingdom
France
Italy
Spain
Rest of Western Europe

2.1.3 Asia-Pacific
2.1.3.1 Market Overview by Asia-Pacific Region
2.1.3.2 Market Overview by Biopharmaceutical Product
2.1.3.3 Market Overview by Biopharmaceutical Therapeutic Area
2.1.3.4 Biopharmaceutical Product Market Overview by Asia-Pacific Region
Monoclonal Antibodies
Biotech Vaccines
Erythropoietin
Granulocyte-Colony Stimulating Factor
Recombinant Human Insulin
Interferons
Human Growth Hormones
Other Biopharmaceuticals
2.1.3.5 Major Market Players
Aurobindo Pharma Ltd. (India)
Aventis Pharma Limited (India)
Beijing SL Pharmaceutical Co., Ltd. (China)
Beijing Tiantan Biological Products Co., Ltd. (China)
Biocon Ltd. (India)
Biological E Limited (India)
Bukwang Pharma (South Korea)
CellResearchCorp (Singapore)
Cipla Ltd (India)
Da An Gene Co., Ltd (China)
Daiichi Sankyo Ltd. (Japan)
Dr. Reddy's Laboratories (India)
Glenmark Pharmaceuticals Ltd. (India)
GVK BIO (India)
Hualan Biological Engineering Inc. (China)
i-DNA Biotechnology (Singapore)
LG Life Sciences (South Korea)
Panacea Biotech Ltd. (India)
Ranbaxy Laboratories Limited (India)
Reliance Life Sciences (India)
RPG Life Sciences Ltd. (India)
SciGen (Singapore)
Shanghai Institute of Biological Products (China)
Shantha Biotechniques Ltd. (India)
Shenzhen Neptunus Bioengineering Co., Ltd. (China)
Sun Pharmaceutical Industries Ltd. (India)
Suven Life Sciences Ltd. (India)
Takeda (Japan)
Torrent Pharmaceuticals Ltd. (India)
Zydus Cadila Ltd. (India)
2.1.3.6 Asia-Pacific Market Overview by Country
Japan
China
India
Rest of Asia-Pacific

2.1.4 Rest of World
2.1.4.1 Market Overview by Biopharmaceutical Product
2.1.4.2 Market Overview by Biopharmaceutical Therapeutic Area
2.1.4.3 Major Market Players
D-Pharm Ltd. (Israel)
Teva Pharmaceutical Industries (Israel)

3. GUIDE TO THE INDUSTRY
3.1 North America
3.1.1 United States
3.1.2 Canada

3.2 Europe
3.2.1 Germany
3.2.2 United Kingdom
3.2.3 France
3.2.4 Belgium
3.2.5 Denmark
3.2.6 Ireland
3.2.7 Norway
3.2.8 Sweden
3.2.9 Switzerland
3.2.10 The Netherlands

3.3 Asia-Pacific
3.3.1 Japan
3.3.2 China
3.3.3 India
3.3.4 Australia
3.3.5 Hong Kong
3.3.6 Indonesia
3.3.7 Malaysia
3.3.8 Singapore
3.3.9 South Korea
3.3.10 Taiwan

3.4 Rest of World
3.4.1 Brazil
3.4.2 Israel

4. ANNEXURE
4.1 Research Methodology
4.2 The Questionnaire
4.3 Feedback

 

Charts & Graphs

GLOBAL MARKET PERSPECTIVE
Chart 1: Global Biopharmaceuticals Market Analysis (2006-2015) by Therapeutic Area – Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million
Chart 2: Glance at 2006, 2010 and 2015 Global Biopharmaceuticals Market Share (%) by Therapeutic Area – Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other
Chart 3: Global Sales of Blog Buster Drugs (2008 & 2009) in USD Million
Chart 4: Global Biopharmaceuticals Market Analysis (2006-2015) in USD Million
Chart 5: Global Biopharmaceuticals Market Analysis (2006-2015) by Product Segment Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 6: Glance at 2006, 2010 and 2015 Global Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
Chart 7: Global Monoclonal Antibodies Market Analysis (2006-2015) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World in USD Million
Chart 8: Glance at 2006, 2010 and 2015 Global Monoclonal Antibodies Market Share (%) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World
Chart 9: Global Biotech Vaccines Market Analysis (2006-2015) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World in USD Million
Chart 10: Glance at 2006, 2010 and 2015 Global Biotech Vaccines Market Share (%) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World
Chart 11: Global Erythropoietin Market Analysis (2006-2015) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World in USD Million
Chart 12: Glance at 2006, 2010 and 2015 Global Erythropoietin Market Share (%) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World
Chart 13: Global G-CSF Market Analysis (2006-2015) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World in USD Million
Chart 14: Glance at 2006, 2010 and 2015 Global G-CSF Market Share (%) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World
Chart 15: Global Monoclonal Antibodies Market Analysis (2006-2015) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World in USD Million
Chart 16: Glance at 2006, 2010 and 2015 Global Monoclonal Antibodies Market Share (%) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World
Chart 17: Global Interferons Market Analysis (2006-2015) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World in USD Million
Chart 18: Glance at 2006, 2010 and 2015 Global Interferons Market Share (%) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World
Chart 19: Global HG Hormones Market Analysis (2006-2015) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World in USD Million
Chart 20: Glance at 2006, 2010 and 2015 Global HG Hormones Market Share (%) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World
Chart 21: Global Other Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World in USD Million
Chart 22: Glance at 2006, 2010 and 2015 Global Other Biopharmaceuticals Market Share (%) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World
Chart 23: Global Biopharmaceuticals Market Analysis (2006-2015) in Oncology by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World in USD Million
Chart 24: Glance at 2006, 2010 and 2015 Global Oncology Market Share (%) of Biopharmaceuticals by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World
Chart 25: Global Biopharmaceuticals Market Analysis (2006-2015) in Neurology by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World in USD Million
Chart 26: Glance at 2006, 2010 and 2015 Global Neurology Market Share (%) of Biopharmaceuticals by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World
Chart 27: Global Biopharmaceuticals Market Analysis (2006-2015) in Diabetes by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World in USD Million
Chart 28: Glance at 2006, 2010 and 2015 Global Diabetes Market Share (%) of Biopharmaceuticals by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World
Chart 29: Global Biopharmaceuticals Market Analysis (2006-2015) in Infectious Diseases by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World in USD Million
Chart 30: Glance at 2006, 2010 and 2015 Global Infectious Diseases Market Share (%) of Biopharmaceuticals by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World
Chart 31: Global Biopharmaceuticals Market Analysis (2006-2015) in Cardiovascular by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World in USD Million
Chart 32: Glance at 2006, 2010 and 2015 Global Cardiovascular Market Share (%) of Biopharmaceuticals by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World
Chart 33: Global Biopharmaceuticals Market Analysis (2006-2015) in Other Disease Areas by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World in USD Million
Chart 34: Glance at 2006, 2010 and 2015 Global Other Disease Areas Market Share (%) of Biopharmaceuticals by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World

REGIONAL MARKET PERSPECTIVE
Chart 35: The Projection of Largest Regions in terms of Market Growth for Biopharmaceuticals by Geography – Asia-Pacific, Europe and North America
Chart 36: Global Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World in USD Million
Chart 37: Glance at 2006, 2010 and 2015 Global Biopharmaceuticals Market Share (%) by Geographic Region – North America, Western Europe, Asia-Pacific and Rest of World

NORTHE AMERICA
Chart 38: North American Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region – United States and Canada in USD Million
Chart 39: Glance at 2006, 2010 and 2015 North American Biopharmaceuticals Market Share (%) by Geographic Region – United States and Canada
Chart 40: North American Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 41: Glance at 2006, 2010 and 2015 North American Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin,Interferons, HG Hormones and Other
Chart 42: North American Biopharmaceuticals Market Analysis (2006-2015) by Therapeutic Area – Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million
Chart 43: Glance at 2006, 2010 and 2015 North American Biopharmaceuticals Market Share (%) by Therapeutic Area – Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other
Chart 44: North American Monoclonal Antibodies Market (2006-2015) by Geographic Region – United States and Canada in USD Million
Chart 45: Glance at 2006, 2010 and 2015 North American Monoclonal Antibodies Market Share (%) by Geographic Region – United States and Canada
Chart 46: North American Biotech Vaccines Market Analysis (2006-2015) by Geographic Region – United States and Canada in USD Million
Chart 47: Glance at 2006, 2010 and 2015 North American Biotech Vaccines Market Share (%) by Geographic Region – United States and Canada
Chart 48: North American Erythropoietin Market Analysis (2006-2015) by Geographic Region – United States and Canada in USD Million
Chart 49: Glance at 2006, 2010 and 2015 North American Erythropoietin Market Share (%) by Geographic Region – United States and Canada
Chart 50: North American G-CSF Market Analysis (2006-2015) by Geographic Region – United States and Canada in USD Million
Chart 51: Glance at 2006, 2010 and 2015 North American G-CSF Market Share (%) by Geographic Region – United States and Canada
Chart 52: North American RH Insulin Market Analysis (2006-2015) by Geographic Region – United States and Canada in USD Million
Chart 53: Glance at 2006, 2010 and 2015 North American RH Insulin Market Share (%) by Geographic Region – United States and Canada
Chart 54: North American Interferons Market Analysis (2006-2015) by Geographic Region – United States and Canada in USD Million
Chart 55: Glance at 2006, 2010 and 2015 North American Interferons Market Share (%) by Geographic Region – United States and Canada
Chart 56: North American HG Hormones Market Analysis (2006-2015) by Geographic Region – United States and Canada in USD Million
Chart 57: Glance at 2006, 2010 and 2015 North American HG Hormones Market Share (%) by Geographic Region – United States and Canada
Chart 58: North American Other Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region – United States and Canada in USD Million
Chart 59: Glance at 2006, 2010 and 2015 North American Other Biopharmaceuticals Market Share (%) by Geographic Region –United States and Canada

The United States
Chart 60: United States Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 61: Glance at 2006, 2010 and 2015 United States Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

Canada
Chart 62: Canadian Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 63: Glance at 2006, 2010 and 2015 Canadian Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

WESTERN EUROPE
Chart 64: Western Europe Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
Chart 65: Glance at 2006, 2010 and 2015 Western Europe Biopharmaceuticals Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain and Rest of WE
Chart 66: Western Europe Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 67: Glance at 2006, 2010 and 2015 Western Europe Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
Chart 68: Western Europe Biopharmaceuticals Market Analysis (2006-2015) by Therapeutic Area – Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million
Chart 69: Glance at 2006, 2010 and 2015 Western Europe Biopharmaceuticals Market Share (%) by Therapeutic Area – Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other
Chart 70: Western Europe Monoclonal Antibodies Market Analysis (2006-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
Chart 71: Glance at 2006, 2010 and 2015 Western Europe Monoclonal Antibodies Market Share (%) by Geographic Region –Germany, United Kingdom, France, Italy, Spain and Rest of WE
Chart 72: Western Europe Biotech Vaccines Market Analysis (2006-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
Chart 73: Glance at 2006, 2010 and 2015 Western Europe Biotech Vaccines Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain and Rest of WE
Chart 74: Western Europe Erythropoietin Market Analysis (2006-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
Chart 75: Glance at 2006, 2010 and 2015 Western Europe Erythropoietin Market Share (%) by Geographic Region –Germany, United Kingdom France, Italy, Spain and Rest of WE
Chart 76: Western Europe G-CSF Market Analysis (2006-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
Chart 77: Glance at 2006, 2010 and 2015 Western Europe G-CSF Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain and Rest of WE
Chart 78: Western Europe RH Insulin Market Analysis (2006-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
Chart 79: Glance at 2006, 2010 and 2015 Western Europe RH Insulin Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain and Rest of WE
Chart 80: Western Europe Interferons Market Analysis (2006-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
Chart 81: Glance at 2006, 2010 and 2015 Western Europe Interferons Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain and Rest of WE
Chart 82: Western Europe HG Hormones Market Analysis (2006-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
Chart 83: Glance at 2006, 2010 and 2015 Western Europe HG Hormones Market Share (%) by Geographic Region – Germany, United Kingdom, France, Italy, Spain and Rest of WE
Chart 84: Western Europe Other Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region – Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
Chart 85: Glance at 2006, 2010 and 2015 Western Europe Other Biopharmaceuticals Market Share (%) by Geographic Region –Germany, United Kingdom, France, Italy, Spain and Rest of WE

Germany
Chart 86: German Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 87: Glance at 2006, 2010 and 2015 German Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

The United Kingdom
Chart 88: United Kingdom Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 89: Glance at 2006, 2010 and 2015 United Kingdom Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

France
Chart 90: French Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 91: Glance at 2006, 2010 and 2015 French Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

Italy
Chart 92: Italian Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 93: Glance at 2006, 2010 and 2015 Italian Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

Spain
Chart 94: Spanish Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 95: Glance at 2006, 2010 and 2015 Spanish Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

Rest of Western Europe
Chart 96: Rest of WE Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 97: Glance at 2006, 2010 and 2015 Rest of WE Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

ASIA-PACIFIC
Chart 98: Asia-Pacific Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region – Japan, China, India and Rest of Asia-Pacific in USD Million
Chart 99: Glance at 2006, 2010 and 2015 Asia-Pacific Biopharmaceuticals Market Share (%) by Geographic Region – Japan, China, India and Rest of Asia-Pacific
Chart 100: Asia-Pacific Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 101: Glance at 2006, 2010 and 2015 Asia-Pacific Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
Chart 102: Asia-Pacific Biopharmaceuticals Market Analysis (2006-2015) by Therapeutic Area – Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million
Chart 103: Glance at 2006, 2010 and 2015 Asia-Pacific Biopharmaceuticals Market Share (%) by Therapeutic Area – Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other
Chart 104: Asia-Pacific Monoclonal Antibodies Market Analysis (2006-2015) by Geographic Region – Japan, China, India and Rest of Asia-Pacific in USD Million
Chart 105: Glance at 2006, 2010 and 2015 Asia-Pacific Monoclonal Antibodies Market Share (%) by Geographic Region – Japan, China, India and Rest of Asia-Pacific
Chart 106: Asia-Pacific Biotech Vaccines Market Analysis (2006-2015) by Geographic Region – Japan, China, India and Rest of Asia-Pacific in USD Million
Chart 107: Glance at 2006, 2010 and 2015 Asia-Pacific Biotech Vaccines Market Share (%) by Geographic Region – Japan, China, India and Rest of Asia-Pacific
Chart 108: Asia-Pacific Erythropoietin Market Analysis (2006-2015) by Geographic Region – Japan, China, India and Rest of Asia-Pacific in USD Million
Chart 109: Glance at 2006, 2010 and 2015 Asia-Pacific Erythropoietin Market Share (%) by Geographic Region – Japan, China, India and Rest of Asia-Pacific
Chart 110: Asia-Pacific G-CSF Market Analysis (2006-2015) by Geographic Region – Japan, China, India and Rest of Asia-Pacific in USD Million
Chart 111: Glance at 2006, 2010 and 2015 Asia-Pacific G-CSF Market Share (%) by Geographic Region – Japan, China, India and Rest of Asia-Pacific
Chart 112: Asia-Pacific RH Insulin Market Analysis (2006-2015) by Geographic Region – Japan, China, India and Rest of Asia-Pacific in USD Million
Chart 113: Glance at 2006, 2010 and 2015 Asia-Pacific RH Insulin Market Share (%) by Geographic Region – Japan, China, India and Rest of Asia-Pacific
Chart 114: Asia-Pacific Interferons Market Analysis (2006-2015) by Geographic Region – Japan, China, India and Rest of Asia-Pacific in USD Million
Chart 115: Glance at 2006, 2010 and 2015 Asia-Pacific Interferons Market Share (%) by Geographic Region – Japan, China, India and Rest of Asia-Pacific
Chart 116: Asia-Pacific HG Hormones Market Analysis (2006-2015) by Geographic Region – Japan, China, India and Rest of Asia-Pacific in USD Million
Chart 117: Glance at 2006, 2010 and 2015 Asia-Pacific HG Hormones Market Share (%) by Geographic Region – Japan, China, India and Rest of Asia-Pacific
Chart 118: Asia-Pacific Other Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region – Japan, China, India and Rest of Asia-Pacific in USD Million
Chart 119: Glance at 2006, 2010 and 2015 Asia-Pacific Other Biopharmaceuticals Market Share (%) by Geographic Region –Japan, China, India and Rest of Asia-Pacific

Japan
Chart 120: Japanese Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 121: Glance at 2006, 2010 and 2015 Japanese Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

China
Chart 122: Chinese Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 123: Glance at 2006, 2010 and 2015 Chinese Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

India
Chart 124: Indian Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 125: Glance at 2006, 2010 and 2015 Indian Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons,HG Hormones and Other

Rest of Asia-Pacific
Chart 126: Rest of Asia-Pacific Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 127: Glance at 2006, 2010 and 2015 Rest of Asia-Pacific Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other

REST OF WORLD
Chart 128: Rest of World Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
Chart 129: Glance at 2006, 2010 and 2015 Rest of World Biopharmaceuticals Market Share (%) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
Chart 130: Rest of World Biopharmaceuticals Market Analysis (2006-2015) by Therapeutic Area – Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million
Chart 131: Glance at 2006, 2010 and 2015 Rest of World Biopharmaceuticals Market Share (%) by Therapeutic Area – Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other

Abbott Laboratories
Alexion Pharma
Ambrilia Biopharma Inc.
Amgen
Analytical Biological Services Inc.
AstraZeneca
Atlanta Biologicals, Inc.
Aventis Pharma Limited
AVI BioPharma
Baxter Bioscience Corporation
Bayer AG
BD Biosciences
Beijing Tiantan Biological Products Co., Ltd.
Biocon Ltd.
Biogen Idec
Bio-Rad Laboratories, Inc.
Boehringer Ingelheim
Bristol-Myers Squibb Belgium NV
Bukwang Pharma
CellResearchCorp
Cipla Ltd
Daiichi Sankyo Ltd.
DNA Gateway International, Inc.
Dr. Reddy’s Laboratories
Eli Lilly
Genentech
Genzyme
GlaxoSmithKline Pharmaceuticals Limited
Glenmark Pharmaceuticals Ltd.
GVK BIO
Helix BioPharma Corp.
Hualan Biological Engineering Inc.
Johnson & Johnson
LG Life Sciences
Merck Serono S.A
Millipore Corporation
Novartis
Novo Nordisk
OSI Pharmaceuticals, Inc.
Pfizer Inc.
Procter & Gamble Pharmaceuticals
Ranbaxy Laboratories Limited
Reliance Life Sciences
Roche
Sandoz Biogenerics
Sanofi-Aventis
Schering Ag
Shantha Biotechniques Ltd.
Sigma-Aldrich Corporation
Solvay Pharma & Cie
Takeda
Teva Pharmaceutical Industries
UCB S.A.

SINGLE USER/ENTERPRISE LICENSE
Electronic (PDF)

ORIGINAL PRICE
$4680
REDUCED PRICE
$1872

Latest Version Available!

Latest version of this report is available. Click below to view report.

Latest Publication
avialable for this report

BT001 – Jul 2013

Have a question
about this report?

EMAIL US

OTHER ARCHIVED REPORTS

Tissue Engineering The Combination of Cells and Engineering

Published
Feb 2012

Monolithic Ceramics Applications A Global Market-Overview

Monolithic Ceramics Applications – A Global Market Overview
Report Code: CP008ARCH | Pages: 310 | Price: $1782

Published
Jun 2011

Medical Ceramics A Global Market Overview

Medical Ceramics - A Global Market Overview
Report Code: CP006ARCH | Pages: 198 | Price: $1800

Published
Jun 2011

Ventilation Equipment A US Market Overview

Ventilation Equipment – A US Market Overview
Report Code: MG003ARCH | Pages: 114 | Price: $1350

Published
May 2011

Ventilation Equipment A European Market Overview

Ventilation Equipment – A European Market Overview
Report Code: MG004ARCH | Pages: 204 | Price: $1782

Published
May 2011